AWS Helps Pfizer Accelerate Drug Development and Clinical Manufacturing

For over
15 years, Amazon Web Services has been the world’s most comprehensive and
broadly adopted cloud offering. AWS has been continually expanding its services
to support virtually any cloud workload, and it now has more than 200 fully
featured services for compute, storage, databases, networking, analytics,
machine learning and artificial intelligence (AI), Internet of Things (IoT),
mobile, security, hybrid, virtual and augmented reality (VR and AR), media, and
application development, deployment, and management from 81 Availability Zones
within 25 geographic regions, with announced plans for 27 more Availability
Zones and nine more AWS Regions in Australia, Canada, India, Indonesia, Israel,
New Zealand, Spain, Switzerland, and the United Arab Emirates. Millions of
customers—including the fastest-growing startups, largest enterprises, and
leading government agencies—trust AWS to power their infrastructure, become
more agile, and lower costs. To learn more about AWS, visit aws.amazon.com.

About Pfizer: Breakthroughs That Change Patients’ Lives

At Pfizer, we apply science and our global resources to
bring therapies to people that extend and significantly improve their lives. We
strive to set the standard for quality, safety and value in the discovery,
development and manufacture of health care products, including innovative
medicines and vaccines. Every day, Pfizer colleagues work across developed and
emerging markets to advance wellness, prevention, treatments and cures that
challenge the most feared diseases of our time. Consistent with our responsibility
as one of the world’s premier innovative biopharmaceutical companies, we
collaborate with health care providers, governments and local communities to
support and expand access to reliable, affordable health care around the world.
For more than 170 years, we have worked to make a difference for all who rely
on us. We routinely post information that may be
important to investors on our website at www.Pfizer.com. In addition, to learn more, please visit us on www.Pfizer.com and follow us on Twitter at @Pfizer
and @Pfizer
News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.

Pfizer Disclosure Notice: The information contained
in this release is as of December 2, 2021. Pfizer assumes no obligation to
update forward-looking statements contained in this release as the result of
new information or future events or developments.

This release contains forward-looking information about an
agreement between Amazon Web Services, Inc. (AWS) and Pfizer to use AWS
analytics, compute, data warehousing, machine learning and storage services to
experiment with innovative solutions, including its potential benefits, that
involve substantial risks and uncertainties that could cause actual results to
differ materially from those expressed or implied by such statements. Risks and
uncertainties include, among other things, the uncertainties inherent in
research and development; uncertainties regarding the commercial success of and
the ability to realize the anticipated benefits of the collaborations;
uncertainties regarding the impact of COVID-19 on our business, operations and
financial results; other business effects, including the effects of industry,
market, economic, political or regulatory conditions; and competitive
developments.

A further description of risks and uncertainties can be
found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December
31, 2020 and in its subsequent reports on Form 10-Q, including in the sections
thereof captioned “Risk Factors” and “Forward-Looking Information and Factors
That May Affect Future Results,” as well as in its subsequent reports on Form
8-K, all of which are filed with the U.S. Securities and Exchange Commission and
available at www.sec.gov and www.pfizer.com.

#AmazonWebServices